Edition:
United States

Allergan plc (AGN)

AGN on New York Consolidated

223.12USD
26 May 2017
Change (% chg)

$-1.24 (-0.55%)
Prev Close
$224.36
Open
$224.41
Day's High
$225.14
Day's Low
$222.95
Volume
1,697,663
Avg. Vol
2,875,329
52-wk High
$261.27
52-wk Low
$184.50

AGN

Chart for AGN

About

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US... (more)

Overall

Beta: 1.16
Market Cap(Mil.): $74,938.65
Shares Outstanding(Mil.): 335.87
Dividend: 0.70
Yield (%): 1.25

Financials

  AGN Industry Sector
P/E (TTM): -- 14.27 17.41
EPS (TTM): -10.56 -- --
ROI: -2.81 -7.17 -5.42
ROE: -5.17 -6.63 -4.68

BRIEF-Allergan announces closing of public offering

* Allergan announces closing of public offering of senior notes to refinance existing debt Source text for Eikon: Further company coverage:

May 26 2017

BRIEF-Allergan prices public offering of senior notes to refinance existing debt

* Allergan announces pricing of public offering of senior notes to refinance existing debt

May 23 2017

BRIEF-Allergan says VIBERZI now approved in Canada

* viberzi™ now approved in canada for patients with irritable bowel syndrome with diarrhea (ibs-d)

May 16 2017

Several top fund managers trim Allergan stakes in first quarter

NEW YORK Six closely watched investors sliced their stakes in Allergan Plc during the first quarter, recent regulatory disclosures show, cutting what had been one of the years' best performing health stocks that has stumbled in recent days.

May 15 2017

Several top fund managers trim Allergan stakes in 1st quarter

NEW YORK, May 15 Six closely watched investors sliced their stakes in Allergan Plc during the first quarter, recent regulatory disclosures show, cutting what had been one of the years' best performing health stocks that has stumbled in recent days.

May 15 2017

BRIEF-Carl Icahn dissolves shared share stake in Allergan

* Carl Icahn dissolves share stake in Allergan Plc - sec filing

May 15 2017

BRIEF-Paulson & Co Inc takes share stake in Dish Network, Monsanto

* Paulson & Co Inc takes share stake of 3.5 million shares in Dish Network Corp

May 15 2017

BRIEF-Appaloosa LP takes share stake in CBS, cuts in Allergan

* Appaloosa lp takes share stake of 1.0 million of class b shares in cbs corp

May 12 2017

Teva first-quarter profit tops estimates, revenue up on Actavis deal

TEL AVIV Israel-based Teva Pharmaceutical Industries reported a smaller-than-expected fall in first-quarter profit on Thursday, with sales boosted by its $40.5 billion acquisition last year of generics drug business Actavis.

May 11 2017

UPDATE 2-Teva Q1 profit tops estimates, revenue up on Actavis deal

* Increases Actavis synergy, cost benefit estimate by $200 mln

May 11 2017

More From Around the Web

Earnings vs. Estimates